Quantcast
Last updated on April 24, 2014 at 21:24 EDT

Latest Immunoglobulin light chain Stories

2012-10-05 02:23:08

CAMBRIDGE, England, October 5, 2012 /PRNewswire/ -- Crescendo Biologics Limited (Crescendo) today announces it has received Notice of Allowance of US 12/476,087 (a continuation of its granted patent US 7,541,513) which covers mice in which the endogenous immunoglobulin lambda light chain locus is functionally deleted. This further extends coverage of the core Crescendo patent family which includes the European patent EP1399559 (inventors: Brueggemann et al.) which was...

2010-09-29 02:58:00

CAMBRIDGE, England, September 29, 2010 /PRNewswire/ -- - Mice Lacking Endogenous Antibody Polypeptides Offer Powerful New Tool for Antibody Fragment Development Crescendo Biologics Limited (Crescendo) today announces it has established a colony of engineered mice completely devoid of endogenous antibody polypeptides. The proprietary 'triple knockout' mice are believed to be unique and have the immunoglobulin heavy chain (IgH), kappa light chain and lambda light chain loci all...